Stocks
ANI Pharmaceuticals (ANIP) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 3.12 | 25.0 | 106.6 | 63.1 | 207.3 | 225.7 | ||
| Changes by years, y/y, % | -89% | +704% | +326% | -41% | +228% | +48.1% | |||
ANI Pharmaceuticals. EBITDA US GAAP, bln rub
ANI Pharmaceuticals. EBITDA US GAAP, changes, %
ANI Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
ANI Pharmaceuticals (ANIP) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 14.9 | 48.4 | 39.2 | 61.2 | 76.9 | 225.7 | |
| Changes by years, y/y, % | -32% | +8% | +130% | -556% | +418% | |||
| Changes by quarters, q/q, % | -211% | +226% | -19% | +56% | +26% | |||
